Skip to main content Accessibility help
×
Home
Hostname: page-component-747cfc64b6-9ng7f Total loading time: 0.219 Render date: 2021-06-12T18:45:43.632Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true }

Article contents

From polipharmacy to monotheraphy a case about schizoaffective disorder

Published online by Cambridge University Press:  23 March 2020

S.F. Salonia
Affiliation:
CSM Yecla, Psychiatry, Yecla, Spain
P.E. Asensio Pascual
Affiliation:
CSM Yecla, Psychiatry, Yecla, Spain
B. Pérez Molina
Affiliation:
CSM Yecla, Psychiatry, Yecla, Spain
A.M. García Herrero
Affiliation:
CSM Yecla, Psychiatry, Yecla, Spain
M.D.C. Martinez Tomás
Affiliation:
CSM Yecla, Psychiatry, Yecla, Spain
J. Martinez Martinez
Affiliation:
CSM Yecla, Nursing, Yecla, Spain
Á.A. Maroto Hernández
Affiliation:
CSM Yecla, Nursing, Yecla, Spain
A.M. Gea Jimenez
Affiliation:
CSM Yecla, Nursing, Yecla, Spain
F.J. Sanchís Lledó
Affiliation:
CSM Yecla, Psychology, Yecla, Spain
M. Infante Sánchez de Lugarnuevo
Affiliation:
CSM Yecla, Psychology, Yecla, Spain

Abstract

The aim of the present poster is to describe an initial complex case of schizoaffective disorder with other clinical adverse conditions (metabolic disorders) in a young adult male, which gradually went into a positive treatment way from polipharmacy to monoteraphy. His psychiatric history started when he was 25-year-old, he was diagnosed of heroine dependence, hypercholesterolemia and hypertrigliceridemia. In 2000 he had a suicide attempt in a context of depressive mood and delusions. He needed a psychiatric hospitalization for the first time in his life and he received anti-psychotics for the first time too. Drug abuse was detected in that hospitalization (cannabis and alcohol). In 2001 was diagnosed of paranoid schizophrenia. In 2007 the diagnosis was modified to schizoaffective disorder and also was detected high blood pressure, Diabetes Mellitus II and overweight. From 2007 to the present he passed from a scheme treatment composed by four or more psychotropic drugs to monotherapy (only one psychotropic drug, an anti-psychotic), he stayed clinically stable and all his metabolic parameters remained equal or improved.

Disclosure of interest

Janssen-Cilag research study.

Type
e-Poster Viewing: Schizophrenia and other psychotic disorders
Copyright
Copyright © European Psychiatric Association 2017
Submit a response

Comments

No Comments have been published for this article.
You have Access

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

From polipharmacy to monotheraphy a case about schizoaffective disorder
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

From polipharmacy to monotheraphy a case about schizoaffective disorder
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

From polipharmacy to monotheraphy a case about schizoaffective disorder
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *